title: Antioxidant activity of nebivolol in the rat aorta.
abstract: The beta-blocker nebivolol is a racemic mixture of D- and L- enantiomers that displays negative inotropic as well as direct vasorelaxant activity. In addition, it has been proposed that nebivolol exerts endothelium-protective effects caused by its antioxidant properties. In the present study we investigated the effect of D-, L-, and d/l-nebivolol on reactive oxygen species (ROS)-induced endothelial damage and compared it with carvedilol and metoprolol. Isolated rat aortic rings were exposed to ROS by electrolysis of the organ bath medium. Before and after electrolysis, endothelial function was measured by preconstricting the vessels with phenylephrine followed by the addition of methacholine. Carvedilol and nebivolol protected against ROS-induced endothelial damage, whereas metoprolol did not. The protective effect of nebivolol proved not to be stereoselective. Furthermore, we attempted to determine whether nebivolol acts a scavenger itself or whether another mechanism is involved. By means of HPLC measurements it was shown that nebivolol concentrations were decreased after exposure to electrolysis-induced ROS, thus indicating that nebivolol is degraded by its reaction with ROS. Functional experiments, in the rat aorta, demonstrated that exposure of nebivolol to ROS also affects its vasodilator activity. In conclusion, the present study demonstrates that nebivolol alleviates ROS-induced impairment of endothelium-dependent vasorelaxation. This protective effect is very likely the result of a direct ROS-scavenging action by the nebivolol molecule itself.
authors.affiliation: Department of Pharmacorherapy, Academic Medical Cener, University of Amsterdam, The Netherlands. a.a.degroot@amc.uva.nl
authors.forename: Annemieke A
authors.initials: AA
authors.lastname: de Groot
authors.forename: Marie-Jeanne
authors.initials: MJ
authors.lastname: Mathy
authors.forename: Pieter A
authors.initials: PA
authors.lastname: van Zwieten
authors.forename: Stephan L M
authors.initials: SL
authors.lastname: Peters
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001011:Aorta; D001578:Benzopyrans / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D004983:Ethanolamines / Q000494:pharmacology*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D000068577:Nebivolol; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D011921:Rats, Inbred WKY; D017382:Reactive Oxygen Species
chemical_list: D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D017382:Reactive Oxygen Species; D000068577:Nebivolol